Skip to main content
Top
Published in: Thrombosis Journal 1/2004

Open Access 01-12-2004 | Original clinical investigation

Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study

Authors: Antonio Vallano, Josep Maria Arnau, Gaietà Permanyer Miralda, Jaume Pérez-Bartolí

Published in: Thrombosis Journal | Issue 1/2004

Login to get access

Abstract

Background

Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been published, which recommend the use of prophylactic heparins in patients with risk of venous thromboembolism (VTE). The aim of this study was the assessment of the prophylaxis of VTE and the adherence to accepted guideline recommendations throughout the hospital.

Methods

A cross-sectional study was carried out in a teaching hospital after guidelines were implemented. Patients' risk factors of deep vein thrombosis, risk categories of patients, and prophylaxis used in different wards were recorded. Appropriate adherence to the guidelines was analysed.

Results

Of 397 patients, prophylaxis was used in 231 patients (58%), and low-molecular-weight heparins (LMWH) were used in 224 of them (97%). Patients with prophylaxis had a higher mean number of risk factors (SD) than those without prophylaxis [3.1 (1.4) vs 1.9 (1.4); p < 0.05)]. Prophylaxis was used in 72% and 90% of moderate and high-risk patients respectively. Appropriate adherence to all guideline recommendations was observed in 42% of patients. Adherence to guidelines was high as regards the use of prophylaxis according to patients' risk factors (78%) and the use of appropriate types of prophylaxis (99%), but was low regarding appropriate heparin dosage (47%) and preoperative dosage (37%). Appropriate prophylaxis use was higher in critical care and surgical wards than in medical wards.

Conclusion

Prophylaxis of VTE is generally used in risk patients, but appropriate adherence to guidelines is less frequent and variable among different wards. Continuing medical education, discussion and dissemination of guidelines, and regular clinical audit are necessary to improve prophylaxis of VTE in clinical practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Colditz GA, Tuden RL, Oster G: Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. Lancet 1986, 2: 143-146. 10.1016/S0140-6736(86)91955-0CrossRefPubMed Colditz GA, Tuden RL, Oster G: Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. Lancet 1986, 2: 143-146. 10.1016/S0140-6736(86)91955-0CrossRefPubMed
2.
go back to reference Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urological surgery. N Engl J Med 1988, 318: 1162-1173.CrossRefPubMed Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urological surgery. N Engl J Med 1988, 318: 1162-1173.CrossRefPubMed
3.
go back to reference Claggett GP, Reisch JS: Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 1988, 208: 227-240.CrossRef Claggett GP, Reisch JS: Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 1988, 208: 227-240.CrossRef
4.
go back to reference Nurmohamed MB, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandebroucke JP, Briet E: Low molecular weight heparin versus standard heparin in general surgery and orthopedic surgery: a meta-analysis. Lancet 1992, 340: 152-156. 10.1016/0140-6736(92)93223-ACrossRefPubMed Nurmohamed MB, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandebroucke JP, Briet E: Low molecular weight heparin versus standard heparin in general surgery and orthopedic surgery: a meta-analysis. Lancet 1992, 340: 152-156. 10.1016/0140-6736(92)93223-ACrossRefPubMed
5.
go back to reference Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP: Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992, 305: 913-920.PubMedCentralCrossRefPubMed Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP: Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992, 305: 913-920.PubMedCentralCrossRefPubMed
6.
go back to reference Imperiale TF, Speroff TA: Meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994, 271: 1780-1785. 10.1001/jama.271.22.1780CrossRefPubMed Imperiale TF, Speroff TA: Meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994, 271: 1780-1785. 10.1001/jama.271.22.1780CrossRefPubMed
7.
go back to reference Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D, Decousus H: Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000, 83: 14-19.PubMed Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D, Decousus H: Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000, 83: 14-19.PubMed
8.
go back to reference Iorio A, Agnelli G: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000, 160: 2327-2332. 10.1001/archinte.160.15.2327CrossRefPubMed Iorio A, Agnelli G: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000, 160: 2327-2332. 10.1001/archinte.160.15.2327CrossRefPubMed
9.
go back to reference Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH: A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001, 16: 293-300. 10.1054/arth.2001.21499CrossRefPubMed Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH: A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001, 16: 293-300. 10.1054/arth.2001.21499CrossRefPubMed
10.
go back to reference Koch A, Ziegler S, Breitschwerdt H, Victor N: Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res 2001, 102: 295-309. 10.1016/S0049-3848(01)00251-1CrossRefPubMed Koch A, Ziegler S, Breitschwerdt H, Victor N: Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res 2001, 102: 295-309. 10.1016/S0049-3848(01)00251-1CrossRefPubMed
11.
go back to reference Thromboembolic Risk Factors (THRIFT) Consensus Group: Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992, 305: 567-574.CrossRef Thromboembolic Risk Factors (THRIFT) Consensus Group: Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992, 305: 567-574.CrossRef
12.
go back to reference Clagett GP, Anderson Jr FA, Heit J, Levine MN, Wheeler HB: Prevention of venous thromboembolism. Chest 1995, 108(4 Suppl):312S-334S.CrossRefPubMed Clagett GP, Anderson Jr FA, Heit J, Levine MN, Wheeler HB: Prevention of venous thromboembolism. Chest 1995, 108(4 Suppl):312S-334S.CrossRefPubMed
13.
go back to reference Clagett GP, Anderson Jr FA, Heit JA, Knudson M, Lieberman Jr, Merli GJ, Wheeler HB, Geets W: Prevention of venous thromboembolism. Chest 1998, 114(5 Suppl):531S-560S.CrossRefPubMed Clagett GP, Anderson Jr FA, Heit JA, Knudson M, Lieberman Jr, Merli GJ, Wheeler HB, Geets W: Prevention of venous thromboembolism. Chest 1998, 114(5 Suppl):531S-560S.CrossRefPubMed
14.
go back to reference Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB: Prevention of venous thromboembolism. Chest 2001, 119(Suppl 1):132-175. 10.1378/chest.119.1_suppl.132SCrossRef Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB: Prevention of venous thromboembolism. Chest 2001, 119(Suppl 1):132-175. 10.1378/chest.119.1_suppl.132SCrossRef
15.
go back to reference Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan A: Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991, 115: 591-595.CrossRefPubMed Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan A: Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991, 115: 591-595.CrossRefPubMed
16.
go back to reference Vallès JA, Vallano A, Torres F, Arnau JM, Laporte JR: Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. Br J Clin Pharmacol 1994, 37: 255-259.PubMedCentralCrossRefPubMed Vallès JA, Vallano A, Torres F, Arnau JM, Laporte JR: Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. Br J Clin Pharmacol 1994, 37: 255-259.PubMedCentralCrossRefPubMed
17.
go back to reference Keane MG, Ingenito EP, Goldhaber SZ: Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest 1994, 106: 13-14.CrossRefPubMed Keane MG, Ingenito EP, Goldhaber SZ: Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest 1994, 106: 13-14.CrossRefPubMed
18.
go back to reference Braztzler DW, Raskob GE, Murray CK, Bumpus LJ, Piatt DS: Underuse of venous thromboembolism prophylaxis for general surgery patients. Arch Intern Med 1998, 158: 1909-1912. 10.1001/archinte.158.17.1909CrossRef Braztzler DW, Raskob GE, Murray CK, Bumpus LJ, Piatt DS: Underuse of venous thromboembolism prophylaxis for general surgery patients. Arch Intern Med 1998, 158: 1909-1912. 10.1001/archinte.158.17.1909CrossRef
19.
go back to reference Vallano A, Vallès JA, Gracia RM, Arnau JM, Duran S, Laporte JR: Use of heparin for the prevention of venous thromboembolism. Pharmacoepidemiol Drug Saf 1994, 3: 211-214.CrossRef Vallano A, Vallès JA, Gracia RM, Arnau JM, Duran S, Laporte JR: Use of heparin for the prevention of venous thromboembolism. Pharmacoepidemiol Drug Saf 1994, 3: 211-214.CrossRef
20.
go back to reference Lepaux DJ, Charpentier C, Pertek JP, Pinelli C, Delagoutte JP, Delorme N, Hoffman M, Lecompte T, Nace L, Voltz C, Wahl D, Briancon S: Assessment of deep vein thrombosis prophylaxis in surgical patients: a study conducted at Nancy University Hospital, France. Eur J Clin Pharmacol 1998, 54: 671-676. 10.1007/s002280050533CrossRefPubMed Lepaux DJ, Charpentier C, Pertek JP, Pinelli C, Delagoutte JP, Delorme N, Hoffman M, Lecompte T, Nace L, Voltz C, Wahl D, Briancon S: Assessment of deep vein thrombosis prophylaxis in surgical patients: a study conducted at Nancy University Hospital, France. Eur J Clin Pharmacol 1998, 54: 671-676. 10.1007/s002280050533CrossRefPubMed
21.
go back to reference George BD, Cook TA, Franlin IJ, Nethercliff J, Galland RB: Protocol violation in deep vein thrombosis prophylaxis. Ann R Coll Surg Engl 1998, 80: 55-57.PubMedCentralPubMed George BD, Cook TA, Franlin IJ, Nethercliff J, Galland RB: Protocol violation in deep vein thrombosis prophylaxis. Ann R Coll Surg Engl 1998, 80: 55-57.PubMedCentralPubMed
22.
go back to reference Egermayer P, Robins C, Town GI: Survey of the use of thromboprophylaxis for medical patients at Christchurch Hospital. N Z Med J 1999, 112: 246-248.PubMed Egermayer P, Robins C, Town GI: Survey of the use of thromboprophylaxis for medical patients at Christchurch Hospital. N Z Med J 1999, 112: 246-248.PubMed
23.
go back to reference Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota A, Haines ST, Hawkins DW, O'Connell MB, Smith RC, Stringer KA: Prevention of venous Thromboembolism. Adherence to the 1995 American College of Chest Physicians Consensus Guidelines for surgical patients. Arch Intern Med 2000, 160: 334-340. 10.1001/archinte.160.3.334CrossRefPubMed Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota A, Haines ST, Hawkins DW, O'Connell MB, Smith RC, Stringer KA: Prevention of venous Thromboembolism. Adherence to the 1995 American College of Chest Physicians Consensus Guidelines for surgical patients. Arch Intern Med 2000, 160: 334-340. 10.1001/archinte.160.3.334CrossRefPubMed
24.
go back to reference Riskpam RP, Trottier SJ: Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU. Chest 1998, 113: 162-164.CrossRef Riskpam RP, Trottier SJ: Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU. Chest 1998, 113: 162-164.CrossRef
25.
go back to reference Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan A: Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994, 154: 669-677. 10.1001/archinte.154.6.669CrossRefPubMed Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan A: Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994, 154: 669-677. 10.1001/archinte.154.6.669CrossRefPubMed
26.
go back to reference McEleney P, Bowie P, Robins JB, Brown RC: Getting a validated guideline into local practice: implementation and audit of the SIGN guideline on the prevention of deep thrombosis in a district general hospital. Scott Med J 1998, 43: 23-25. McEleney P, Bowie P, Robins JB, Brown RC: Getting a validated guideline into local practice: implementation and audit of the SIGN guideline on the prevention of deep thrombosis in a district general hospital. Scott Med J 1998, 43: 23-25.
27.
go back to reference Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342: 1317-1322. 10.1016/0140-6736(93)92244-NCrossRefPubMed Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342: 1317-1322. 10.1016/0140-6736(93)92244-NCrossRefPubMed
28.
go back to reference Byrne GJ, McCarthy MJ, Silverman SH: Improving uptake of prophylaxis for venous thromboembolism in general surgical patients using prospective audit. BMJ 1996, 313: 917.PubMedCentralCrossRefPubMed Byrne GJ, McCarthy MJ, Silverman SH: Improving uptake of prophylaxis for venous thromboembolism in general surgical patients using prospective audit. BMJ 1996, 313: 917.PubMedCentralCrossRefPubMed
29.
go back to reference Hull RD, Hirsh J, Sackett DL, Stoddart GL: Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J 1982, 127: 990-995.PubMedCentralPubMed Hull RD, Hirsh J, Sackett DL, Stoddart GL: Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J 1982, 127: 990-995.PubMedCentralPubMed
30.
go back to reference Szucs TD, Schramm W: The cost-effectiveness of low-molecular-weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis for the German healthcare system. Pharmacol Res 1999, 40: 83-89. 10.1006/phrs.1999.0479CrossRefPubMed Szucs TD, Schramm W: The cost-effectiveness of low-molecular-weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis for the German healthcare system. Pharmacol Res 1999, 40: 83-89. 10.1006/phrs.1999.0479CrossRefPubMed
31.
go back to reference Matzsch T: Thromboprophylaxis with low-molecular-weight heparin: economic considerations. Haemostasis 2000, 30(Suppl 2):141-145.PubMed Matzsch T: Thromboprophylaxis with low-molecular-weight heparin: economic considerations. Haemostasis 2000, 30(Suppl 2):141-145.PubMed
32.
go back to reference Bell GK, Goldhaber SZ: Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Vasc Med 2001, 6: 23-29. 10.1191/135886301670156965CrossRefPubMed Bell GK, Goldhaber SZ: Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Vasc Med 2001, 6: 23-29. 10.1191/135886301670156965CrossRefPubMed
Metadata
Title
Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study
Authors
Antonio Vallano
Josep Maria Arnau
Gaietà Permanyer Miralda
Jaume Pérez-Bartolí
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2004
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/1477-9560-2-3

Other articles of this Issue 1/2004

Thrombosis Journal 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.